The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
AXL pathway as a target to overcome resistance to PARP inhibitors in high-grade serous ovarian (HGSOC) and triple-negative breast cancer (TNBC) cell lines.
 
Jose Alejandro Perez-Fidalgo
Consulting or Advisory Role - Ability Pharma; Amgen; AstraZeneca; Clovis Oncology; GlaxoSmithKline; Roche; Tesaro
Speakers' Bureau - AstraZeneca Spain; Clovis Oncology; GlaxoSmithKline; Ipsen; Novartis; Pfizer; PharmaMar; Roche; Seagen
Research Funding - AstraZeneca Spain (Inst); GlaxoSmithKline (Inst); Pharmamar (Inst)
Patents, Royalties, Other Intellectual Property - Pending patent
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; Pfizer; Roche
(OPTIONAL) Uncompensated Relationships - AstraZeneca Spain; Novartis
 
Juan Jose Martinez Pretel
No Relationships to Disclose
 
Paloma Sanchez Serrano
No Relationships to Disclose
 
Victoria Heredia
No Relationships to Disclose
 
Jan Hochstadt
No Relationships to Disclose
 
Marta Mendiola
Honoraria - AstraZeneca; GlaxoSmithKline; MSD Oncology
Research Funding - Eisai (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; Pfizer; PharmaMar; Roche
 
Andres Redondo
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Clovis Oncology; GlaxoSmithKline; PharmaMar
Speakers' Bureau - AstraZeneca; Clovis Oncology; GlaxoSmithKline; MSD; PharmaMar
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; PharmaMar
 
Lidia Gonzalez Villena
No Relationships to Disclose
 
Miriam Ruiz Linuesa
No Relationships to Disclose
 
Begona Pineda
Research Funding - AstraZeneca (Inst); PharmaMar (Inst)